• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从血培养中分离出的草绿色链球菌的体外抗菌药敏性。

In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures.

作者信息

Potgieter E, Carmichael M, Koornhof H J, Chalkley L J

机构信息

Emergent Pathogen Research Unit, South African Medical Research Council, School of Pathology, University of the Witwatersand, Parktown, Johannesburg.

出版信息

Eur J Clin Microbiol Infect Dis. 1992 Jun;11(6):543-6. doi: 10.1007/BF01960811.

DOI:10.1007/BF01960811
PMID:1526239
Abstract

The susceptibility of 211 viridans streptococci isolated from blood cultures to eight antimicrobial agents was determined. All the isolates were susceptible to cefotaxime, ceftriaxone, imipenem and vancomycin. Thirty eight percent of the isolates were resistant to penicillin (MICs greater than or equal to 0.25 micrograms/ml). Tetracycline resistance was found in 41% of the isolates and in 7% of these strains tetracycline resistance was combined with erythromycin resistance. Five Streptococcus mitis isolates exhibited increased (MIC 64 micrograms/ml and 128 micrograms/ml) or high-level (MIC greater than or equal to 500 micrograms/ml) resistance to gentamicin, kanamycin and tobramycin. Four of these isolates were also resistant to penicillin (MICs 16-32 micrograms/m). In vitro synergy was not demonstrated for combinations of penicillin and gentamicin against three Streptococcus mitis isolates with gentamicin MICs of 1000, 128 and 64 micrograms/ml. Results of this study indicate the importance of monitoring antibiotic resistance trends in viridans streptococci particularly with respect to penicillin and aminoglycoside resistance.

摘要

测定了从血培养中分离出的211株草绿色链球菌对8种抗菌药物的敏感性。所有分离株对头孢噻肟、头孢曲松、亚胺培南和万古霉素敏感。38%的分离株对青霉素耐药(最低抑菌浓度大于或等于0.25微克/毫升)。41%的分离株对四环素耐药,其中7%的菌株对四环素耐药并伴有对红霉素耐药。5株缓症链球菌分离株对庆大霉素、卡那霉素和妥布霉素表现出增加(最低抑菌浓度为64微克/毫升和128微克/毫升)或高水平(最低抑菌浓度大于或等于500微克/毫升)耐药。其中4株分离株也对青霉素耐药(最低抑菌浓度为16 - 32微克/毫升)。对于青霉素和庆大霉素联合用于3株最低抑菌浓度分别为1000、128和64微克/毫升的缓症链球菌分离株,未显示体外协同作用。本研究结果表明监测草绿色链球菌抗生素耐药趋势的重要性,尤其是对青霉素和氨基糖苷类耐药方面。

相似文献

1
In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures.从血培养中分离出的草绿色链球菌的体外抗菌药敏性。
Eur J Clin Microbiol Infect Dis. 1992 Jun;11(6):543-6. doi: 10.1007/BF01960811.
2
Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States.美国草绿色链球菌中出现高比例的抗菌药物耐药性。
Antimicrob Agents Chemother. 1996 Apr;40(4):891-4. doi: 10.1128/AAC.40.4.891.
3
Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis.台湾草绿色链球菌群的抗菌药敏性,重点关注口腔链球菌对青霉素和大环内酯类药物的高耐药率。
J Antimicrob Chemother. 1998 Jun;41(6):621-7. doi: 10.1093/jac/41.6.621.
4
[Susceptibility to penicillin and 13 antimicrobial agents in erythromycin-resistant viridans group streptococci isolated from blood cultures].[从血培养中分离出的对红霉素耐药的草绿色链球菌对青霉素和13种抗菌药物的敏感性]
Rev Esp Quimioter. 2001 Sep;14(3):275-80.
5
Viridans group streptococci in blood culture isolates in a Swedish university hospital: antibiotic susceptibility and identification of erythromycin resistance genes.瑞典一家大学医院血培养分离出的草绿色链球菌:抗生素敏感性及红霉素耐药基因鉴定
Int J Antimicrob Agents. 2006 Oct;28(4):292-6. doi: 10.1016/j.ijantimicag.2006.05.032. Epub 2006 Aug 30.
6
In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.八种大环内酯类抗生素及RP-59500(奎奴普丁-达福普汀)对从中性粒细胞减少的癌症患者血液中分离出的草绿色链球菌的体外活性。
Antimicrob Agents Chemother. 1996 Sep;40(9):2117-20. doi: 10.1128/AAC.40.9.2117.
7
Enhanced activity of the combination of penicillin G and gentamicin against penicillin-resistant viridans group streptococci.青霉素G与庆大霉素联合使用对耐青霉素的草绿色链球菌的活性增强。
Antimicrob Agents Chemother. 1995 Dec;39(12):2816-8. doi: 10.1128/AAC.39.12.2816.
8
[Antibiotic resistance analysis of isolates from the hospitalized children in Shanxi Children's Hospital from 2012 to 2014].[2012年至2014年山西儿童医院住院患儿分离株的抗生素耐药性分析]
Zhonghua Er Ke Za Zhi. 2017 Feb 2;55(2):109-114. doi: 10.3760/cma.j.issn.0578-1310.2017.02.011.
9
Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci.青霉素、氨苄西林和万古霉素与氨基糖苷类药物对非肠球菌D群链球菌和草绿色链球菌的协同作用。
J Med Microbiol. 1977 Feb;10(1):133-8. doi: 10.1099/00222615-10-1-133.
10
Antibiotic susceptibility of clinical isolates of Streptococcus pneumoniae.肺炎链球菌临床分离株的抗生素敏感性
Chemotherapy. 1996 Jul-Aug;42(4):240-7. doi: 10.1159/000239450.

引用本文的文献

1
The clinical Spectrum of Viridans Group Streptococci infections in paediatric patients at a tertiary hospital.一家三级医院儿科患者中草绿色链球菌感染的临床谱
S Afr J Infect Dis. 2024 Apr 29;39(1):563. doi: 10.4102/sajid.v39i1.563. eCollection 2024.
2
Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.从癌症中性粒细胞减少患者血液中分离出的草绿色链球菌的分子关系及抗菌药敏性
J Clin Microbiol. 1999 Jun;37(6):1876-80. doi: 10.1128/JCM.37.6.1876-1880.1999.
3
High incidence of erythromycin-resistant streptococci in Taiwan.

本文引用的文献

1
Multiply resistant viridans streptococci: susceptibility to beta-lactam antibiotics and comparison of penicillin-binding protein patterns.多重耐药草绿色链球菌:对β-内酰胺类抗生素的敏感性及青霉素结合蛋白模式比较
Antimicrob Agents Chemother. 1983 Nov;24(5):702-5. doi: 10.1128/AAC.24.5.702.
2
Resistance to penicillin-streptomycin synergy among clinical isolates of viridans streptococci.草绿色链球菌临床分离株对青霉素 - 链霉素协同作用的耐药性。
Antimicrob Agents Chemother. 1983 Dec;24(6):871-5. doi: 10.1128/AAC.24.6.871.
3
Meningitis caused by multiply antibiotic-resistant viridans streptococci.
台湾地区红霉素耐药性链球菌的高发病率。
Antimicrob Agents Chemother. 1997 Apr;41(4):844-6. doi: 10.1128/AAC.41.4.844.
4
Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.头孢噻肟。对其抗菌活性和药代动力学特性的重新评估,以及对其每日两次给药治疗轻至中度感染时的治疗效果的综述。
Drugs. 1997 Mar;53(3):483-510. doi: 10.2165/00003495-199753030-00009.
5
Species belonging to the "Streptococcus milleri" group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens.属于“米勒链球菌”组的菌种:重要临床标本中的抗菌药物敏感性及比较患病率
J Clin Microbiol. 1996 Aug;34(8):2020-2. doi: 10.1128/jcm.34.8.2020-2022.1996.
6
Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.亚胺培南/西司他丁:其抗菌活性、药代动力学及治疗严重感染疗效的最新进展
Drugs. 1996 Jan;51(1):99-136. doi: 10.2165/00003495-199651010-00008.
7
Prospective study of Streptococcus milleri bacteremia.米勒链球菌菌血症的前瞻性研究。
Eur J Clin Microbiol Infect Dis. 1996 Mar;15(3):194-200. doi: 10.1007/BF01591353.
8
Emerging resistance to antimicrobial agents in gram-positive bacteria. Enterococci, staphylococci and nonpneumococcal streptococci.革兰氏阳性菌中对抗菌药物的新出现耐药性。肠球菌、葡萄球菌和非肺炎链球菌。
Drugs. 1996;51 Suppl 1:6-12. doi: 10.2165/00003495-199600511-00004.
9
Defining antibody targets in Streptococcus oralis infection.确定口腔链球菌感染中的抗体靶点。
Infect Immun. 1996 May;64(5):1600-8. doi: 10.1128/iai.64.5.1600-1608.1996.
10
Enhanced activity of the combination of penicillin G and gentamicin against penicillin-resistant viridans group streptococci.青霉素G与庆大霉素联合使用对耐青霉素的草绿色链球菌的活性增强。
Antimicrob Agents Chemother. 1995 Dec;39(12):2816-8. doi: 10.1128/AAC.39.12.2816.
J Pediatr. 1984 Dec;105(6):891-5. doi: 10.1016/s0022-3476(84)80072-4.
4
Ribosomal resistance of clinical enterococcal to streptomycin isolates.临床分离的肠球菌对链霉素的核糖体耐药性。
Antimicrob Agents Chemother. 1984 Mar;25(3):398-9. doi: 10.1128/AAC.25.3.398.
5
Molecular genetics of resistance to macrolides, lincosamides and streptogramin B (MLS) in streptococci.链球菌对大环内酯类、林可酰胺类及链阳菌素B(MLS)耐药的分子遗传学
J Antimicrob Chemother. 1985 Jul;16 Suppl A:111-35. doi: 10.1093/jac/16.suppl_a.111.
6
Differentiation of Streptococcus sanguis and S. mitior by whole-cell rhamnose content and possession of arginine dihydrolase.通过全细胞鼠李糖含量和精氨酸二水解酶的有无来鉴别血链球菌和轻链球菌。
J Med Microbiol. 1986 May;21(3):189-97. doi: 10.1099/00222615-21-3-189.
7
Drug resistance patterns and serogroups or serotypes of pneumococcal isolates from cerebrospinal fluid or blood, 1979-1986.1979 - 1986年从脑脊液或血液中分离出的肺炎球菌菌株的耐药模式及血清群或血清型
J Infect Dis. 1988 Nov;158(5):956-64. doi: 10.1093/infdis/158.5.956.
8
Functions and activities of the Area Committee on Microbiology of the National Committee for Clinical Laboratory Standards.国家临床实验室标准委员会微生物学地区委员会的职能与活动。
Clin Microbiol Rev. 1991 Apr;4(2):150-5. doi: 10.1128/CMR.4.2.150.
9
Combined resistance to erythromycin and tetracycline in streptococci.
J Antimicrob Chemother. 1991 Jul;28(1):154-6. doi: 10.1093/jac/28.1.154.
10
The Garrod Lecture. The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options.加罗德讲座。肠球菌:抗菌药物耐药性对治疗选择影响的经典实例。
J Antimicrob Chemother. 1991 Jul;28(1):1-12. doi: 10.1093/jac/28.1.1.